Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells
暂无分享,去创建一个
T. Mcclanahan | R. Pierce | R. Kastelein | J. Yearley | J. Phillips | D. Laface | D. Cua | B. Basham | D. Gorman | R. Mangadu | E. Bowman | R. Jain | C. Chang | J. Mumm | I. Chan | G. Ayanoglu | M. Sathe | M. Tessmer | C. Moon | S. Turner | F. Vives | E. Peñaflor
[1] M. De Allegri,et al. Maternal and perinatal mortality by place of delivery in sub-Saharan Africa: a meta-analysis of population-based cohort studies , 2014, BMC Public Health.
[2] F. Powrie,et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model , 2013, The Journal of experimental medicine.
[3] R. Locksley,et al. Innate lymphoid cells — a proposal for uniform nomenclature , 2013, Nature Reviews Immunology.
[4] C. Datz,et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth , 2012, Nature.
[5] F. Powrie,et al. Identification of a genetic locus controlling bacteria-driven colitis and associated cancer through effects on innate inflammation , 2012, The Journal of experimental medicine.
[6] T. Mcclanahan,et al. IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells , 2012, Nature Medicine.
[7] W. Ouyang,et al. Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice , 2011, Mucosal Immunology.
[8] F. Jirik,et al. Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in mice. , 2011, The Journal of clinical investigation.
[9] R. Pierce,et al. IL-23 Is Critical for Induction of Arthritis, Osteoclast Formation, and Maintenance of Bone Mass , 2011, The Journal of Immunology.
[10] S. Travis,et al. IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease , 2011, The Journal of experimental medicine.
[11] B. Becher,et al. IL-12 initiates tumor rejection via lymphoid tissue–inducer cells bearing the natural cytotoxicity receptor NKp46 , 2010, Nature Immunology.
[12] C. Tato,et al. Innate IL-17-producing cells: the sentinels of the immune system , 2010, Nature Reviews Immunology.
[13] C. Tato,et al. Innate IL-17-producing cells: the sentinels of the immune system , 2010, Nature Reviews Immunology.
[14] Michael Karin,et al. Inflammation and colon cancer. , 2010, Gastroenterology.
[15] F. Powrie,et al. Innate lymphoid cells drive IL-23 dependent innate intestinal pathology , 2010, Nature.
[16] P. Munkholm,et al. Risk of Extra-Intestinal Cancer in Inflammatory Bowel Disease: Meta-Analysis of Population-Based Cohort Studies , 2010, The American Journal of Gastroenterology.
[17] M. Karin,et al. Immunity, Inflammation, and Cancer , 2010, Cell.
[18] S. Gaffen,et al. Interleukin‐17 and its target genes: mechanisms of interleukin‐17 function in disease , 2010, Immunology.
[19] Cynthia L Sears,et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses , 2009, Nature Medicine.
[20] L. Augenlicht,et al. Macrophage-derived IL-1β stimulates Wnt signaling and growth of colon cancer cells; a crosstalk interrupted by vitamin D3 , 2009, Oncogene.
[21] P. Kosmidis,et al. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. , 2009, Anticancer research.
[22] V. Kuchroo,et al. Cutting Edge: IL-23 Receptor GFP Reporter Mice Reveal Distinct Populations of IL-17-Producing Cells1 , 2009, The Journal of Immunology.
[23] M. Karin,et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. , 2009, Cancer cell.
[24] G. Bhagat,et al. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. , 2008, Cancer cell.
[25] M. Oft,et al. Cytokine-based transformation of immune surveillance into tumor-promoting inflammation , 2008, Oncogene.
[26] K. Maloy,et al. IL-23 and Th17 cytokines in intestinal homeostasis , 2008, Mucosal Immunology.
[27] J. Karras,et al. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. , 2008, The Journal of clinical investigation.
[28] S. Sa,et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens , 2008, Nature Medicine.
[29] N. Mukaida,et al. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. , 2008, The Journal of clinical investigation.
[30] S. Itzkowitz,et al. Cancer in inflammatory bowel disease. , 2008, World journal of gastroenterology.
[31] T. Mak,et al. TNF-α is critical for antitumor but not antiviral T cell immunity in mice , 2007 .
[32] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[33] Judy H. Cho,et al. A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.
[34] T. Mcclanahan,et al. IL-23 promotes tumour incidence and growth , 2006, Nature.
[35] K. Herrmann,et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[36] P. Munkholm. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease , 2003, Alimentary pharmacology & therapeutics.
[37] J. Kleibeuker,et al. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas , 2003, The Lancet.
[38] T. Mcclanahan,et al. A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R1 , 2002, The Journal of Immunology.
[39] J. Ward,et al. IL-6 transgenic mouse model for extraosseous plasmacytoma , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Leach,et al. Ubiquitous Transgenic Expression of the IL-23 Subunit p19 Induces Multiorgan Inflammation, Runting, Infertility, and Premature Death , 2001, The Journal of Immunology.
[41] E. Kliewer,et al. Cancer risk in patients with inflammatory bowel disease , 2001, Cancer.
[42] S. Leeder,et al. A population based study , 1993, The Medical journal of Australia.
[43] T. Mak,et al. TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice. , 2007, The Journal of clinical investigation.
[44] R. Kastelein,et al. Understanding the IL-23-IL-17 immune pathway. , 2006, Trends in immunology.
[45] J. Baron,et al. Nonsteroidal anti-inflammatory drugs and cancer prevention. , 2000, Annual review of medicine.